Skip to content

Clinical efficacy of therapy with T-705 in patients with severe fever with thrombocytopenia syndrome

Clinical efficacy of therapy with T-705 in patients with severe fever with thrombocytopenia syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043342
Enrollment
Unknown
Registered
2021-02-11
Start date
2018-09-01
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe fever with thrombocytopenia syndrome

Interventions

Sponsors

The 990th Hospital of Chinese People's Liberation Army Joint Logistic Support Force
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Based on the criteria of severe fever with thrombocytopenia syndrome as defined by the Chinese Ministry of Health.

Exclusion criteria

Exclusion criteria: 1. Aged < 18 years; 2. Have a fertility plan in the near future; 3. Pregnant or lactational women; 4. With psychopaths and were not effectively controlled; 5. Having a history of gout or in the treatment of gout or hyperuricemia; hereditary xanthuria, or a history of low uric acid (<1 mg/dl), and urethral xanthine stone; 6. Having a history of hypersensitivity to an antiviral nucleoside-analog drug targeting a viral RNA polymerase; 7. Patients who are unsuitable for the trial for other reasons according to the researcher's evaluation.

Design outcomes

Primary

MeasureTime frame
Mortality rate;

Secondary

MeasureTime frame
Clinical symptoms;time for the clinical symptoms disappeared;viral load of SFTSV;

Countries

China

Contacts

Public ContactYuan Chun

The 990th Hospital of Chinese People's Liberation Army Joint Logistic Support Force

yuanchun282@sina.com+86 13837688212

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026